Showing 9 companies
CIQ
CIQ
5 jobs
Software
51 - 200 employees
Series A

CIQ is a provider of enterprise-grade support for Rocky Linux and other open-source solutions, offering a comprehensive suite of tools and services that enhance security, compliance, and performance. Their business model focuses on delivering commercially-supported versions of community-driven software, ensuring legal indemnification and verified packages for enterprises. CIQ differentiates itself through its commitment to high performance, operational efficiency, and tailored environments, catering to regulated industries and organizations looking to optimize their software infrastructure. With a strong emphasis on community support and innovation, CIQ positions itself as a leader in the enterprise Linux market, helping clients tackle complex challenges and unlock the potential of data and AI.

Elisity
Elisity
6 jobs
Security
Software
51 - 200 employees
Series B

Elisity is a pioneering cybersecurity firm that offers an innovative identity-based microsegmentation platform designed to enhance network security and simplify policy management. Founded in 2018, the company focuses on enabling organizations to achieve Zero Trust maturity by providing comprehensive visibility and control over all devices on their networks. Elisity's platform integrates seamlessly with existing infrastructure, allowing for rapid deployment and real-time policy enforcement without the need for additional hardware. The company has gained traction in various industries, including healthcare and industrial networks, and is recognized for its ability to prevent lateral movement of threats and streamline compliance efforts.

Biotechnology
DeepTech
Health
11 - 50 employees

FYR Diagnostics is a Montana-based CLIA-certified laboratory that develops innovative liquid biopsy solutions utilizing Extracellular Vesicles and other biomarkers to address unmet diagnostic needs in healthcare. Founded in 2018, the company has evolved to provide high-throughput testing and advanced bioinformatics, aiming to improve the accuracy and efficiency of disease diagnostics. Their commitment to bridging gaps between healthcare, patients, and disease positions them as a leader in next-generation diagnostics, with a focus on transforming healthcare through scientific innovation and community engagement.

Telecommunication
51 - 200 employees

Graphiant is a Silicon Valley-based startup offering a next-gen private Network-as-a-Service (NaaS) that simplifies enterprise networking. Their flagship product, Graphiant Network Edge, provides fast, secure, and agile connectivity between hybrid clouds, network edges, customers, and partners. By combining the performance of MPLS with the agility of internet-class services, Graphiant enables enterprises to provision networks in minutes rather than weeks, ensuring lower total costs of ownership and enhanced security. The company is positioned to address the complexities of modern networking, making it an attractive option for enterprises looking to streamline their connectivity solutions.

Biotechnology
DeepTech
Health
11 - 50 employees
Series A

Inimmune is a clinical-stage biotech company focused on the discovery and development of innovative immunotherapies for cancer, allergy, and autoimmune diseases. Their pipeline includes two clinical-stage Toll-like receptor (TLR) agonists and several pre-clinical programs aimed at creating next-generation vaccine adjuvants. Founded by experienced pharmaceutical professionals, Inimmune leverages extensive expertise in immunology and drug formulation to drive their innovative therapies forward, aiming to make meaningful clinical impacts in human health.

Biotechnology
DeepTech
Health
11 - 50 employees
Seed

Novoron Bioscience is a biotechnology company focused on developing first-in-class therapies to restore the regenerative capacity of the brain and spinal cord. Their innovative approach targets low-density lipoprotein receptors to address neurological damage and diseases, including Alzheimer's, multiple sclerosis, and spinal cord injuries. With a meticulous drug development process, Novoron aims to bring effective treatments to patients with unmet medical needs, positioning itself as a leader in neuroregeneration and remyelination in the central nervous system.

Biotechnology
Data and Analytics
DeepTech
Health
Software
11 - 50 employees
Series A

Pulse Data is an AI healthcare company focused on revolutionizing the detection and understanding of chronic diseases, particularly cardiorenal disease. By leveraging advanced AI models, Pulse Data provides predictive insights that help healthcare organizations identify chronic diseases earlier and implement targeted interventions. Their patented technology enables healthcare professionals to improve patient outcomes and reduce costs by delivering timely and actionable data. With a commitment to addressing chronic disease underdiagnosis and health inequities, Pulse Data positions itself as a leader in the healthcare analytics space, trusted by numerous healthcare organizations.

Data and Analytics
DeepTech
Design
Software
51 - 200 employees
Series B

Selector is a leading Network AIOps company that leverages AI and machine learning to enhance operational intelligence across multi-cloud infrastructures. Their platform provides comprehensive visibility and automation capabilities, enabling organizations to proactively detect and resolve network issues, thereby reducing downtime and improving overall performance. With a focus on intelligent issue detection and resolution, Selector's solutions are designed to streamline operations, enhance incident management, and optimize resource allocation, making them a valuable partner for enterprises aiming to maintain high service levels in complex IT environments.

Consumer Products
Data and Analytics
Hardware
Software
51 - 200 employees
Series B

TileDB is foundational software designed for scientific discovery, enabling teams to manage, analyze, and collaborate on structured and unstructured multimodal data. Built on a powerful array database, it addresses the complexities of non-traditional data types, such as genomic variants and biomedical imaging. TileDB is utilized by major pharmaceutical companies and biotech firms to enhance their multi-omics data platforms, driving drug and target discovery through a unified, secure environment that promotes collaboration and accelerates scientific breakthroughs.